RALDEXON^® acts on the Central Nervous System (CNS) selectively in the forebrain for the treatment of elderly patients showing lesions of higher cortical functions.

Effective in improving symptoms attributable to cerebral atrophy for the elderly and expressed as mental and cognitive functions impairment.

In particular, a significant improvement of cognitive functions is described in elderly patients with cognitive impairment, and especially memory improvement of recent and foretime learning, attention, concentration, logic and abstract functions.

RALDEXON^® stimulates the central cholinergic system and interacts with the metabolism of neurons, particularly neuropeptide catabolism.